19 octubre 2015
New data from clinical trials demonstrate the technology’s potential advantages over conventional radiation, including less side effects and survival in some cases, for several harder-to-treat tumors: pancreatic, late-stage, non-small cell lung and chordoma and chondrosarcoma, two rare cancers found in bone or soft tissue.
http://www.sciencedaily.com/releases/2015/10/151019191803.htm
